← Back to Search

Autonomic Modulation Training for Stress (AMT Trial)

N/A
Recruiting
Led By Judith P Andersen, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to follow-up (immediate post intervention assessment)
Awards & highlights

Summary

This trial aims to test a web-based training intervention to build resilience and wellness capacity among police officers exposed to PTSI, and examine sex and gender as central determinants of health.

Who is the study for?
This trial is for active duty frontline law enforcement officers in Canada who speak English fluently. It's designed to help police officers build resilience and wellness capacity, potentially reducing symptoms of post-traumatic stress injuries (PTSI).
What is being tested?
The study tests Autonomic Modulation Training (AMT), a web-based program aimed at improving resilience against stress and trauma. The effectiveness of AMT will be compared to traditional in-person training methods.
What are the potential side effects?
Since the intervention involves non-invasive training techniques, significant side effects are not anticipated. However, participants may experience emotional discomfort or increased awareness of stress during the process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to follow-up (immediate post intervention assessment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to follow-up (immediate post intervention assessment) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alcohol use
Anxiety symptoms
Burnout symptoms
+24 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Participants randomized to the experimental group will complete baseline assessments, the 6 week AMT treatment online and then complete the follow up assessment (8 weeks total)
Group II: ControlActive Control1 Intervention
Participants randomized to the control group will be matched to the experimental group on demographic and outcome measures. Control participants will take the baseline assessments, will wait 7 weeks and take the follow-up assessment (8 weeks total). Control group participants are able to enrol in the AMT intervention at the end of their wait-list control period.

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
705 Previous Clinical Trials
1,021,301 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,373 Previous Clinical Trials
26,518,992 Total Patients Enrolled
Judith P Andersen, PhDPrincipal InvestigatorUniversity of Toronto
~107 spots leftby Dec 2025